{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:00:21Z","timestamp":1772002821283,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"national institute on drug abuse","doi-asserted-by":"publisher","award":["P01 DA028555"],"award-info":[{"award-number":["P01 DA028555"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"national institute of mental health","doi-asserted-by":"publisher","award":["R01MH115860"],"award-info":[{"award-number":["R01MH115860"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"national institute of mental health","doi-asserted-by":"publisher","award":["R01MH121402"],"award-info":[{"award-number":["R01MH121402"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"nih office of the director","doi-asserted-by":"publisher","award":["R24OD018546"],"award-info":[{"award-number":["R24OD018546"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11481-021-10011-w","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T16:03:13Z","timestamp":1631721793000},"page":"796-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice"],"prefix":"10.1007","volume":"16","author":[{"given":"Hang","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sruthi","family":"Sravanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brady","family":"Sillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Waight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumi","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa Y.","family":"Poluektova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhi","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8250-2359","authenticated-orcid":false,"given":"Prasanta K.","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"issue":"9","key":"10011_CR1","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41591-020-1022-1","volume":"26","author":"M Abdel-Mohsen","year":"2020","unstructured":"Abdel-Mohsen M et al (2020) Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nat Med 26(9):1339\u20131350","journal-title":"Nat Med"},{"issue":"Suppl 2","key":"10011_CR2","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1097\/QAD.0000000000002269","volume":"33","author":"C Abreu","year":"2019","unstructured":"Abreu C et al (2019) Brain macrophages harbor latent, infectious simian immunodeficiency virus. AIDS 33(Suppl 2):S181\u2013S188","journal-title":"AIDS"},{"key":"10011_CR3","doi-asserted-by":"publisher","first-page":"23513","DOI":"10.1038\/srep23513","volume":"6","author":"M Arainga","year":"2016","unstructured":"Arainga M et al (2016) HIV-1 cellular and tissue replication patterns in infected humanized mice. Sci Rep 6:23513","journal-title":"Sci Rep"},{"key":"10011_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01186-17","author":"CR Avalos","year":"2017","unstructured":"Avalos CR et al (2017) Brain macrophages in simian immunodeficiency virus-infected, antiretroviral-suppressed macaques: a functional latent reservoir. Mbio. https:\/\/doi.org\/10.1128\/mBio.01186-17","journal-title":"Mbio"},{"issue":"3","key":"10011_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2016.03.021","volume":"165","author":"DH Barouch","year":"2016","unstructured":"Barouch DH et al (2016) Rapid inflammasome activation following mucosal SIV infection of Rhesus monkeys. Cell 165(3):656\u2013667","journal-title":"Cell"},{"issue":"7731","key":"10011_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","volume":"563","author":"EN Borducchi","year":"2018","unstructured":"Borducchi EN et al (2018) Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys. Nature 563(7731):360\u2013364","journal-title":"Nature"},{"issue":"4","key":"10011_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1172\/JCI134815","volume":"130","author":"A Chaillon","year":"2020","unstructured":"Chaillon A et al (2020) HIV persists throughout deep tissues with repopulation from multiple anatomical sources. J Clin Investig 130(4):1699\u20131712","journal-title":"J Clin Investig"},{"key":"10011_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.virol.2017.04.011","volume":"507","author":"P Charlins","year":"2017","unstructured":"Charlins P et al (2017) A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads. Virology 507:135\u2013139","journal-title":"Virology"},{"issue":"11","key":"10011_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","volume":"13","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Ances BM (2013) HIV-associated neurocognitive disorder. Lancet Infect Dis 13(11):976\u2013986","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10011_CR10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","volume":"10","author":"PK Dash","year":"2019","unstructured":"Dash PK et al (2019) Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun 10(1):2753","journal-title":"Nat Commun"},{"issue":"11","key":"10011_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/17425247.2017.1288212","volume":"14","author":"B Edagwa","year":"2017","unstructured":"Edagwa B et al (2017) Long-acting slow effective release antiretroviral therapy. Expert Opin Drug Deliv 14(11):1281\u20131291","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10011_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/QAD.0000000000001267","volume":"31","author":"L Gama","year":"2017","unstructured":"Gama L et al (2017) Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS 31(1):5\u201314","journal-title":"AIDS"},{"key":"10011_CR13","first-page":"111","volume":"417","author":"L Gama","year":"2018","unstructured":"Gama L et al (2018) SIV latency in macrophages in the CNS. Curr Top Microbiol Immunol 417:111\u2013130","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"10011_CR14","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.2353\/ajpath.2010.100536","volume":"177","author":"S Gorantla","year":"2010","unstructured":"Gorantla S et al (2010a) Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol 177(6):2938\u20132949","journal-title":"Am J Pathol"},{"issue":"12","key":"10011_CR15","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.4049\/jimmunol.1000438","volume":"184","author":"S Gorantla","year":"2010","unstructured":"Gorantla S et al (2010b) CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J Immunol 184(12):7082\u20137091","journal-title":"J Immunol"},{"issue":"3","key":"10011_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tins.2011.12.006","volume":"35","author":"S Gorantla","year":"2012","unstructured":"Gorantla S, Poluektova L, Gendelman HE (2012) Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci 35(3):197\u2013208","journal-title":"Trends Neurosci"},{"issue":"6","key":"10011_CR17","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1128\/JVI.02010-06","volume":"81","author":"S Gorantla","year":"2007","unstructured":"Gorantla S et al (2007) Human immunodeficiency virus type 1 pathobiology studied in humanized BALB\/c-Rag2-\/-gammac-\/- mice. J Virol 81(6):2700\u20132712","journal-title":"J Virol"},{"issue":"1","key":"10011_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s13365-010-0005-2","volume":"17","author":"DR Graham","year":"2011","unstructured":"Graham DR et al (2011) Initiation of HAART during acute simian immunodeficiency virus infection rapidly controls virus replication in the CNS by enhancing immune activity and preserving protective immune responses. J Neurovirol 17(1):120\u2013130","journal-title":"J Neurovirol"},{"issue":"23","key":"10011_CR19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75(23):2087\u20132096","journal-title":"Neurology"},{"key":"10011_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00375-19","author":"LJ Henderson","year":"2020","unstructured":"Henderson LJ et al (2020) Advances toward curing HIV-1 infection in tissue reservoirs. J Virol. https:\/\/doi.org\/10.1128\/JVI.00375-19","journal-title":"J Virol"},{"issue":"5","key":"10011_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/M14-1027","volume":"161","author":"TJ Henrich","year":"2014","unstructured":"Henrich TJ et al (2014) Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann Intern Med 161(5):319\u2013327","journal-title":"Ann Intern Med"},{"issue":"11","key":"10011_CR22","doi-asserted-by":"publisher","first-page":"e1002417","DOI":"10.1371\/journal.pmed.1002417","volume":"14","author":"TJ Henrich","year":"2017","unstructured":"Henrich TJ et al (2017) HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study. PLoS Med 14(11):e1002417","journal-title":"PLoS Med"},{"issue":"3","key":"10011_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho YC et al (2013) Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155(3):540\u2013551","journal-title":"Cell"},{"key":"10011_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.10.008","volume":"45","author":"S Hong","year":"2015","unstructured":"Hong S, Banks WA (2015) Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain Behav Immun 45:1\u201312","journal-title":"Brain Behav Immun"},{"issue":"20","key":"10011_CR25","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1128\/JVI.00674-16","volume":"90","author":"SL Lamers","year":"2016","unstructured":"Lamers SL et al (2016) HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads. J Virol 90(20):8968\u20138983","journal-title":"J Virol"},{"key":"10011_CR26","first-page":"1","volume":"323","author":"AM Lerner","year":"2019","unstructured":"Lerner AM, Eisinger RW, Fauci AS (2019) Comorbidities in persons with HIV: the lingering challenge. JAMA 323:1\u201319","journal-title":"JAMA"},{"issue":"8","key":"10011_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMc1413931","volume":"372","author":"K Luzuriaga","year":"2015","unstructured":"Luzuriaga K et al (2015) Viremic relapse after HIV-1 remission in a perinatally infected child. N Engl J Med 372(8):786\u2013788","journal-title":"N Engl J Med"},{"issue":"1","key":"10011_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-virology-101416-041703","volume":"4","author":"MD Marsden","year":"2017","unstructured":"Marsden MD, Zack JA (2017) Humanized mouse models for human immunodeficiency virus infection. Annu Rev Virol 4(1):393\u2013412","journal-title":"Annu Rev Virol"},{"issue":"1","key":"10011_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13024-019-0311-y","volume":"14","author":"S Mathews","year":"2019","unstructured":"Mathews S et al (2019) Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice. Mol Neurodegener 14(1):12","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10011_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1310\/AW2H-TP5C-NP43-K6BY","volume":"7","author":"B McGee","year":"2006","unstructured":"McGee B, Smith N, Aweeka F (2006) HIV pharmacology: barriers to the eradication of HIV from the CNS. HIV Clin Trials 7(3):142\u2013153","journal-title":"HIV Clin Trials"},{"issue":"9","key":"10011_CR31","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/infdis\/jiv230","volume":"212","author":"KA Metcalf Pate","year":"2015","unstructured":"Metcalf Pate KA et al (2015) A murine viral outgrowth assay to detect residual HIV type 1 in patients with undetectable viral loads. J Infect Dis 212(9):1387\u20131396","journal-title":"J Infect Dis"},{"issue":"5","key":"10011_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D et al (2016) HIV-associated neurocognitive disorder\u2014pathogenesis and prospects for treatment. Nat Rev Neurol 12(5):309","journal-title":"Nat Rev Neurol"},{"key":"10011_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2018.00344","volume":"9","author":"K Schmitt","year":"2018","unstructured":"Schmitt K, Akkina R (2018) Ultra-sensitive HIV-1 latency viral outgrowth assays using humanized mice. Front Immunol 9:344","journal-title":"Front Immunol"},{"issue":"1","key":"10011_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41467-018-02885-x","volume":"9","author":"B Sillman","year":"2018","unstructured":"Sillman B et al (2018) Creation of a long-acting nanoformulated dolutegravir. Nat Commun 9(1):443","journal-title":"Nat Commun"},{"key":"10011_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fimmu.2019.00340","volume":"10","author":"H Su","year":"2019","unstructured":"Su H et al (2019) Immune activations and viral tissue compartmentalization during progressive HIV-1 infection of humanized mice. Front Immunol 10:340","journal-title":"Front Immunol"},{"key":"10011_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fcimb.2020.00038","volume":"10","author":"H Su","year":"2020","unstructured":"Su H et al (2020) Amplification of replication competent HIV-1 by adoptive transfer of human cells from infected humanized mice. Front Cell Infect Microbiol 10:38","journal-title":"Front Cell Infect Microbiol"},{"key":"10011_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","volume":"9","author":"C Wallet","year":"2019","unstructured":"Wallet C et al (2019) Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infect Microbiol 9:362","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10011_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/cmi.2012.7","volume":"9","author":"L Zhang","year":"2012","unstructured":"Zhang L, Su L (2012) HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol 9(3):237\u2013244","journal-title":"Cell Mol Immunol"},{"key":"10011_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.biomaterials.2017.10.023","volume":"151","author":"T Zhou","year":"2018","unstructured":"Zhou T et al (2018) Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials 151:53\u201365","journal-title":"Biomaterials"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-021-10011-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-021-10011-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-021-10011-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T08:08:44Z","timestamp":1640765324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-021-10011-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10011"],"URL":"https:\/\/doi.org\/10.1007\/s11481-021-10011-w","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols involving the use of laboratory animals were approved by the University of Nebraska Medical Center (UNMC) Institutional Animal Care and Use Committee (IACUC) ensuring the ethical care and use of laboratory animals in experimental research. Human blood cells were isolated by leukapheresis from HIV-1\/2 and hepatitis seronegative donors and were deemed exempt from approval by the Institutional Review Board (IRB) of UNMC. Human CD34+ hematopoietic stem cells were isolated from human umbilical cord blood and are exempt from UNMC IRB approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"HEG is the co-founder of Exavir Therapeutics, Inc, a company formed to develop extended action antiretroviral drug therapies. All the other authors have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}